Clinical Trials Browser

Phase NA × Withdrawn × Prostatic Neoplasms × Clear all

NCT05014295 2026-02-24

Patient Recall of Cancer Screening and Diagnosis

Phase NA Withdrawn

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT03027986 2026-02-17

PROTOMEN

Phase NA Withdrawn

Prostatic Neoplasms, Urinary Incontinence

NCT03274778 2025-11-18

Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells

Phase NA Withdrawn

Prostatic Neoplasms

NCT04645810 2025-10-15

A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Phase NA Withdrawn

Prostatic Neoplasms

NCT02588846 2024-11-18

KOALA

Phase NA Withdrawn

Prostatic Neoplasms

NCT04312191 2024-10-08

Using Meditation for Oncology Anxiety

Phase NA Withdrawn

Anxiety Disorders, Prostatic Neoplasms

NCT03459755 2024-09-19

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors

Phase NA Withdrawn

Prostatic Neoplasms

NCT05929300 2024-09-19

A Yoga Program for Patients Undergoing Prostate Cancer Surgery

Phase NA Withdrawn

Erectile Dysfunction, Prostatic Neoplasms, Urinary Incontinence

NCT05415696 2024-08-09

Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Phase NA Withdrawn

Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT03909893 2024-03-19

ARTGU

Phase NA Withdrawn

Urinary Bladder Neoplasms, Prostatic Neoplasms

NCT05156372 2024-02-26

HIIT PCa

Phase NA Withdrawn

Motor Activity, Prostatic Neoplasms

NCT04304079 2024-01-23

A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery

Phase NA Withdrawn

Prostatic Neoplasms

NCT05035732 2024-01-18

A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)

Phase NA Withdrawn

Prostatic Neoplasms

NCT05454371 2023-11-13

URODETECT-WP2

Phase NA Withdrawn

Neoplasms, Prostatic Neoplasms

NCT01555632 2023-08-14

Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

Phase NA Withdrawn

Prostatic Neoplasms

NCT00499291 2023-05-25

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Phase NA Withdrawn

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Teratoma, Testicular, Teratoma, Ovarian, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Teratoma, Testicular Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma

NCT05245435 2023-03-20

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT04797078 2023-03-10

FLAPP

Phase NA Withdrawn

Prostatic Neoplasms

NCT03987568 2022-12-21

Characterize Tumor Hypoxia by Magnetic Resonance Imaging

Phase NA Withdrawn

Prostatic Neoplasms

NCT02290366 2022-08-29

Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT03823001 2022-05-20

Virtual Prostate Biopsy Protocol for Patients on Active Surveillance and at Risk of Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT04765423 2022-04-01

Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease

Phase NA Withdrawn

Prostatic Neoplasms

NCT00482157 2022-03-03

Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance

Phase NA Withdrawn

Prostatic Neoplasms

NCT03935308 2022-02-25

MRgRTPCa

Phase NA Withdrawn

Prostatic Neoplasms

NCT02108613 2021-07-29

Living Well on Androgen Deprivation Therapy

Phase NA Withdrawn

Prostatic Neoplasms

NCT04486846 2021-06-10

Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)

Phase NA Withdrawn

Prostatic Neoplasms

NCT01566045 2021-04-28

MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT03589781 2021-03-30

Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate

Phase NA Withdrawn

Prostatic Neoplasms

NCT02295163 2021-03-10

Stellate Ganglion Block for Hot Flushes in Men Treated With ADT

Phase NA Withdrawn

Prostatic Neoplasms, Hot Flashes

NCT04027270 2020-12-17

Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients Undergoing Prostatectomy

Phase NA Withdrawn

Prostatic Neoplasms

NCT03308734 2020-11-24

Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT01691976 2020-11-20

Mild Cognitive Impairment in Men Following Androgen Deprivation

Phase NA Withdrawn

Prostatic Neoplasms, Cognitive Dysfunction

NCT04399824 2020-11-06

Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT03596710 2020-07-23

Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand Therapy

Phase NA Withdrawn

Prostatic Neoplasms

NCT02430649 2020-05-27

IRE

Phase NA Withdrawn

Prostatic Neoplasms

NCT03748719 2020-05-22

Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT03293602 2019-11-27

MISOBOLD

Phase NA Withdrawn

Prostatic Neoplasms

NCT03408561 2019-09-17

Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer

Phase NA Withdrawn

BreastGastrointestinalGenitourinaryLymphoidThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Lymphoma, Prostatic Neoplasms

NCT03514927 2019-08-22

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT03157947 2019-07-05

Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT01811810 2019-04-23

Proton Therapy for High Risk Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT03014973 2018-09-13

HORM

Phase NA Withdrawn

Prostatic Neoplasms

NCT02179762 2018-08-09

EASE

Phase NA Withdrawn

Motor Activity, Prostatic Neoplasms

NCT00996749 2018-07-03

Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT02206724 2018-04-20

Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT02546427 2018-02-12

Hypofractionated Whole Pelvic Radiotherapy of the Prostate

Phase NA Withdrawn

Prostatic Neoplasms

NCT02232672 2017-10-13

Choline PET/CT vs. MeAIB PET/CT in Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT03173807 2017-10-06

ProNEST

Phase NA Withdrawn

Prostatic Neoplasms, Metabolic Syndrome

NCT01748110 2017-01-26

HIM-UP

Phase NA Withdrawn

Prostatic Neoplasms, Urinary Incontinence

NCT02169063 2016-08-31

Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms